SOPHiA GENETICS Prices $50M Public Offering at $4.75 Per Share
SOPH sits 81% above its 52-week low of $2.59 on elevated volume (1.9× avg).
Summary
SOPHiA GENETICS has priced its public offering of 10.526 million ordinary shares at $4.75 per share, aiming to raise $50 million in gross proceeds. This follows the company's announcement yesterday of a proposed public offering and the filing of a preliminary prospectus. The offering is material, representing approximately 14% of the company's market capitalization, and will result in significant dilution for existing shareholders. The company also granted underwriters a 30-day option to purchase an additional 1.5789 million shares. The offering is expected to close on June 18, 2026.
At the time of this announcement, SOPH was trading at $4.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $353.3M. The 52-week trading range was $2.59 to $5.70. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.